Trade

Metropolis Healthcare share price

Balanced risk
  • 27%Low risk
  • 27%Moderate risk
  • 27%Balanced risk
  • 27%High risk
  • 27%Extreme risk
  • 1,905.75(-0.03%)
    January 14, 2026 12:18:26 PM IST
    • NSE
    • BSE
  • Vol : 91.90 K (NSE + BSE)
    Last 20 day avg : 54.07 K

Metropolis Healthcare is trading -0.03% lower at Rs 1,905.75 as compared to its last closing price. Metropolis Healthcare has been trading in the price range of 1,989.95 & 1,892.15. Metropolis Healthcare has given -1.15% in this year & -6.06% in the last 5 days. Metropolis Healthcare has TTM P/E ratio 66.37 as compared to the sector P/E of 26.54.There are 18 analysts who have initiated coverage on Metropolis Healthcare. There are 6 analysts who have given it a strong buy rating & 7 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 52.67 Crores in its last quarter.Listed peers of Metropolis Healthcare include Apollo Hospitals Enterprise (-0.09%), Narayana Hrudayalaya (2.36%), Global Health (0.43%).The Mutual Fund holding in Metropolis Healthcare was at 30.69% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Metropolis Healthcare was at 12.52% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 14, 2026, 06:48 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.68
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.15
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.21
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    7.30
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    61.38
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -5.01
    Indicates undervaluation
Price range
Day Range
Lowest
1,892.15
Highest
1,989.95
52 week range
Lowest
1,383.70
Highest
2,259.30
Metropolis Healthcare Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Apollo Hospitals Enterprise
Bullish
7,306.00-0.091,05,108.0071.0912.560.2683.18
Narayana Hrudayalaya
Bullish
1,931.802.3639,215.5847.6610.510.2459.03
Global Health
Bearish
1,173.650.4331,568.2061.739.450.0418.41
Max Healthcare Institute
Bearish
1,036.000.731,00,793.1593.4311.210.1429.50
Fortis Healthcare
Neutral
913.700.6668,881.8780.047.640.1125.92
Mutual Fund Ownership
View all
NJ ELSS Tax Saver Scheme Regular Growth
NA
  • Amount Invested (Cr.) 10.92
  • % of AUM 4.03
HDFC Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 41.30
  • % of AUM 2.42
LIC MF Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 1.92
  • % of AUM 2.28
Tata Focused Equity Fund Regular Growth
3/5
  • Amount Invested (Cr.) 37.51
  • % of AUM 2.09
JM Aggressive Hybrid Fund Growth
4/5
  • Amount Invested (Cr.) 16.81
  • % of AUM 2.04
Metropolis Healthcare Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-04Quarterly Results & Interim Dividend
2025-08-07Quarterly Results
2025-05-13Audited Results
2025-02-04Quarterly Results
2024-12-09Preferential issue of shares
About the company Metropolis Healthcare
  • IndustryHealthcare Facilities
  • ISININE112L01020
  • BSE Code542650
  • NSE CodeMETROPOLIS
Metropolis Healthcare Limited is engaged in providing diagnostic services to patients, healthcare providers, and corporates across India and Africa. The Company has a single operating segment, namely Pathology services. It is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. It serves a diverse customer base, including B2C, B2B, and institutional clients. It offers a comprehensive range of more than 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. Its footprint spans 28 states, seven Union Territories, and over 750 towns in India, supported by a robust network of more than 220 laboratories, 4,450+ service centers, and over 10,000 touchpoints.
  • Management Info
  • Ameera ShahExecutive Chairman of the Board
  • Surendran ChemmenkottilChief Executive Officer
  • Sameer PatelChief Financial Officer
  • Nilesh ShahPresident Internal Assurance and Advisor to Chief Executive Officer
  • Diya SuriChief People Officer
  • Pinakin ShahChief Information Officer
  • Mohan MenonChief Marketing Officer
  • Kirti ChadhaChief Scientific Officer, Innovation Officer and Group Head CSR
  • Kamlesh KulkarniCompliance Officer, Company Secretary, Head - Legal and Secretarial
  • Kannan AlangadanChief Business Officer - South India
Metropolis Healthcare Share Price FAQs

Metropolis Healthcare is trading at 1905.75 as on Wed Jan 14 2026 06:48:26. This is -0.03% lower as compared to its previous closing price of 1906.25.

The market capitalization of Metropolis Healthcare is 9865.37 Cr as on Wed Jan 14 2026 06:48:26.

The average broker rating on Metropolis Healthcare is Buy. The breakup of analyst rating is given below -

  • 6 analysts have given a strong buy rating
  • 7 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 3 analysts have given a sell rating
  • 1 analysts have given a strong sell rating

The 52 wk high for Metropolis Healthcare is 2259.30 whereas the 52 wk low is 1383.70

Metropolis Healthcare can be analyzed on the following key metrics -

  • TTM P/E: 66.37
  • Sector P/E: 26.54
  • Dividend Yield: 0.21%
  • D/E ratio: 0.14

Metropolis Healthcare reported a net profit of 144.97 Cr in 2025.

The Mutual Fund Shareholding was 30.69% at the end of 30 Sep 2025.